2,5-bis[9-(4,6-diphenyl-1,3,5-triazin-2-yl)carbazol-2-yl]-1,3,4-oxadiazole;2,5-bis[9-[3-(4,6-diphenyl-1,3,5-triazin-2-yl)phenyl]carbazol-2-yl]-1,3,4-oxadiazole;2-[9-(4,6-diphenylpyrimidin-2-yl)carbazol-2-yl]-5-(9-phenylcarbazol-2-yl)-1,3,4-oxadiazole;2-(9-phenylcarbazol-2-yl)-5-[9-(6-pyridin-3-yl-2-pyridinyl)carbazol-2-yl]-1,3,4-oxadiazole

C214H132N32O4 — CID 158043222

IUPAC2,5-bis[9-(4,6-diphenyl-1,3,5-triazin-2-yl)carbazol-2-yl]-1,3,4-oxadiazole;2,5-bis[9-[3-(4,6-diphenyl-1,3,5-triazin-2-yl)phenyl]carbazol-2-yl]-1,3,4-oxadiazole;2-[9-(4,6-diphenylpyrimidin-2-yl)carbazol-2-yl]-5-(9-phenylcarbazol-2-yl)-1,3,4-oxadiazole;2-(9-phenylcarbazol-2-yl)-5-[9-(6-pyridin-3-yl-2-pyridinyl)carbazol-2-yl]-1,3,4-oxadiazole
SMILESc1ccc(-c2cc(-c3ccccc3)nc(-n3c4ccccc4c4ccc(-c5nnc(-c6ccc7c8ccccc8n(-c8ccccc8)c7c6)o5)cc43)n2)cc1.c1ccc(-c2nc(-c3ccccc3)nc(-c3cccc(-n4c5ccccc5c5ccc(-c6nnc(-c7ccc8c9ccccc9n(-c9cccc(-c%10nc(-c%11ccccc%11)nc(-c%11ccccc%11)n%10)c9)c8c7)o6)cc54)c3)n2)cc1.c1ccc(-c2nc(-c3ccccc3)nc(-n3c4ccccc4c4ccc(-c5nnc(-c6ccc7c8ccccc8n(-c8nc(-c9ccccc9)nc(-c9ccccc9)n8)c7c6)o5)cc43)n2)cc1.c1ccc(-n2c3ccccc3c3ccc(-c4nnc(-c5ccc6c7ccccc7n(-c7cccc(-c8cccnc8)n7)c6c5)o4)cc32)cc1
InChIInChI=1S/C68H42N10O.C56H34N10O.C48H30N6O.C42H26N6O/c1-5-19-43(20-6-1)61-69-62(44-21-7-2-8-22-44)72-65(71-61)47-27-17-29-51(39-47)77-57-33-15-13-31-53(57)55-37-35-49(41-59(55)77)67-75-76-68(79-67)50-36-38-56-54-32-14-16-34-58(54)78(60(56)42-50)52-30-18-28-48(40-52)66-73-63(45-23-9-3-10-24-45)70-64(74-66)46-25-11-4-12-26-46;1-5-17-35(18-6-1)49-57-50(36-19-7-2-8-20-36)60-55(59-49)65-45-27-15-13-25-41(45)43-31-29-39(33-47(43)65)53-63-64-54(67-53)40-30-32-44-42-26-14-16-28-46(42)66(48(44)34-40)56-61-51(37-21-9-3-10-22-37)58-52(62-56)38-23-11-4-12-24-38;1-4-14-31(15-5-1)40-30-41(32-16-6-2-7-17-32)50-48(49-40)54-43-23-13-11-21-37(43)39-27-25-34(29-45(39)54)47-52-51-46(55-47)33-24-26-38-36-20-10-12-22-42(36)53(44(38)28-33)35-18-8-3-9-19-35;1-2-11-30(12-3-1)47-36-16-6-4-13-31(36)33-21-19-27(24-38(33)47)41-45-46-42(49-41)28-20-22-34-32-14-5-7-17-37(32)48(39(34)25-28)40-18-8-15-35(44-40)29-10-9-23-43-26-29/h1-42H;1-34H;1-30H;1-26H
InChIKeyFIPIRMPMFMZXDM-UHFFFAOYSA-N
MW3215.63 g/mol
LogP50.38
Rot. Bonds29

About 2,5-bis[9-(4,6-diphenyl-1,3,5-triazin-2-yl)carbazol-2-yl]-1,3,4-oxadiazole;2,5-bis[9-[3-(4,6-diphenyl-1,3,5-triazin-2-yl)phenyl]carbazol-2-yl]-1,3,4-oxadiazole;2-[9-(4,6-diphenylpyrimidin-2-yl)carbazol-2-yl]-5-(9-phenylcarbazol-2-yl)-1,3,4-oxadiazole;2-(9-phenylcarbazol-2-yl)-5-[9-(6-pyridin-3-yl-2-pyridinyl)carbazol-2-yl]-1,3,4-oxadiazole

2,5-bis[9-(4,6-diphenyl-1,3,5-triazin-2-yl)carbazol-2-yl]-1,3,4-oxadiazole;2,5-bis[9-[3-(4,6-diphenyl-1,3,5-triazin-2-yl)phenyl]carbazol-2-yl]-1,3,4-oxadiazole;2-[9-(4,6-diphenylpyrimidin-2-yl)carbazol-2-yl]-5-(9-phenylcarbazol-2-yl)-1,3,4-oxadiazole;2-(9-phenylcarbazol-2-yl)-5-[9-(6-pyridin-3-yl-2-pyridinyl)carbazol-2-yl]-1,3,4-oxadiazole (PubChem CID 158043222) has the molecular formula C214H132N32O4 and a molecular weight of 3215.63 g/mol. Its IUPAC name is 2,5-bis[9-(4,6-diphenyl-1,3,5-triazin-2-yl)carbazol-2-yl]-1,3,4-oxadiazole;2,5-bis[9-[3-(4,6-diphenyl-1,3,5-triazin-2-yl)phenyl]carbazol-2-yl]-1,3,4-oxadiazole;2-[9-(4,6-diphenylpyrimidin-2-yl)carbazol-2-yl]-5-(9-phenylcarbazol-2-yl)-1,3,4-oxadiazole;2-(9-phenylcarbazol-2-yl)-5-[9-(6-pyridin-3-yl-2-pyridinyl)carbazol-2-yl]-1,3,4-oxadiazole.

Molecular Properties

Compound Name2,5-bis[9-(4,6-diphenyl-1,3,5-triazin-2-yl)carbazol-2-yl]-1,3,4-oxadiazole;2,5-bis[9-[3-(4,6-diphenyl-1,3,5-triazin-2-yl)phenyl]carbazol-2-yl]-1,3,4-oxadiazole;2-[9-(4,6-diphenylpyrimidin-2-yl)carbazol-2-yl]-5-(9-phenylcarbazol-2-yl)-1,3,4-oxadiazole;2-(9-phenylcarbazol-2-yl)-5-[9-(6-pyridin-3-yl-2-pyridinyl)carbazol-2-yl]-1,3,4-oxadiazole
PubChem CID158043222
Molecular FormulaC214H132N32O4
Molecular Weight3215.63 g/mol
Exact Mass3213.11
IUPAC Name2,5-bis[9-(4,6-diphenyl-1,3,5-triazin-2-yl)carbazol-2-yl]-1,3,4-oxadiazole;2,5-bis[9-[3-(4,6-diphenyl-1,3,5-triazin-2-yl)phenyl]carbazol-2-yl]-1,3,4-oxadiazole;2-[9-(4,6-diphenylpyrimidin-2-yl)carbazol-2-yl]-5-(9-phenylcarbazol-2-yl)-1,3,4-oxadiazole;2-(9-phenylcarbazol-2-yl)-5-[9-(6-pyridin-3-yl-2-pyridinyl)carbazol-2-yl]-1,3,4-oxadiazole
SMILESc1ccc(-c2cc(-c3ccccc3)nc(-n3c4ccccc4c4ccc(-c5nnc(-c6ccc7c8ccccc8n(-c8ccccc8)c7c6)o5)cc43)n2)cc1.c1ccc(-c2nc(-c3ccccc3)nc(-c3cccc(-n4c5ccccc5c5ccc(-c6nnc(-c7ccc8c9ccccc9n(-c9cccc(-c%10nc(-c%11ccccc%11)nc(-c%11ccccc%11)n%10)c9)c8c7)o6)cc54)c3)n2)cc1.c1ccc(-c2nc(-c3ccccc3)nc(-n3c4ccccc4c4ccc(-c5nnc(-c6ccc7c8ccccc8n(-c8nc(-c9ccccc9)nc(-c9ccccc9)n8)c7c6)o5)cc43)n2)cc1.c1ccc(-n2c3ccccc3c3ccc(-c4nnc(-c5ccc6c7ccccc7n(-c7cccc(-c8cccnc8)n7)c6c5)o4)cc32)cc1
InChIInChI=1S/C68H42N10O.C56H34N10O.C48H30N6O.C42H26N6O/c1-5-19-43(20-6-1)61-69-62(44-21-7-2-8-22-44)72-65(71-61)47-27-17-29-51(39-47)77-57-33-15-13-31-53(57)55-37-35-49(41-59(55)77)67-75-76-68(79-67)50-36-38-56-54-32-14-16-34-58(54)78(60(56)42-50)52-30-18-28-48(40-52)66-73-63(45-23-9-3-10-24-45)70-64(74-66)46-25-11-4-12-26-46;1-5-17-35(18-6-1)49-57-50(36-19-7-2-8-20-36)60-55(59-49)65-45-27-15-13-25-41(45)43-31-29-39(33-47(43)65)53-63-64-54(67-53)40-30-32-44-42-26-14-16-28-46(42)66(48(44)34-40)56-61-51(37-21-9-3-10-22-37)58-52(62-56)38-23-11-4-12-24-38;1-4-14-31(15-5-1)40-30-41(32-16-6-2-7-17-32)50-48(49-40)54-43-23-13-11-21-37(43)39-27-25-34(29-45(39)54)47-52-51-46(55-47)33-24-26-38-36-20-10-12-22-42(36)53(44(38)28-33)35-18-8-3-9-19-35;1-2-11-30(12-3-1)47-36-16-6-4-13-31(36)33-21-19-27(24-38(33)47)41-45-46-42(49-41)28-20-22-34-32-14-5-7-17-37(32)48(39(34)25-28)40-18-8-15-35(44-40)29-10-9-23-43-26-29/h1-42H;1-34H;1-30H;1-26H
InChIKeyFIPIRMPMFMZXDM-UHFFFAOYSA-N
XLogP50.38
TPSA401.36 Ų
H-Bond Donors
H-Bond Acceptors36
Rotatable Bonds29
Heavy Atoms250
Complexity—

Lipinski Rule of Five

3 violations

RuleValue
MW ≤ 5003215.63
LogP ≤ 550.38
H-Bond Donors ≤ 50
H-Bond Acceptors ≤ 1036

Analyze 2,5-bis[9-(4,6-diphenyl-1,3,5-triazin-2-yl)carbazol-2-yl]-1,3,4-oxadiazole;2,5-bis[9-[3-(4,6-diphenyl-1,3,5-triazin-2-yl)phenyl]carbazol-2-yl]-1,3,4-oxadiazole;2-[9-(4,6-diphenylpyrimidin-2-yl)carbazol-2-yl]-5-(9-phenylcarbazol-2-yl)-1,3,4-oxadiazole;2-(9-phenylcarbazol-2-yl)-5-[9-(6-pyridin-3-yl-2-pyridinyl)carbazol-2-yl]-1,3,4-oxadiazole with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

2-[6-(5-Methyl-1,3,4-oxadiazol-2-YL)-1H-indol-1-YL]-1-[4-(pyrimidin-2-YL)piperazin-1-YL]ethan-1-one
CID 53013383
N-[5-[2-[3-[4-[2-[3-[6-[[5-fluoro-1-(pyridin-4-ylmethyl)indole-6-carbonyl]amino]-2-pyridinyl]-1,2,4-triazol-4-yl]propyl]-6-[[1-[2-(1-phenylethoxy)ethyl]imidazo[4,5-c]pyridine-6-carbonyl]amino]-2-pyridinyl]-1,2,4-triazol-4-yl]propyl]-6-(4-propan-2-yl-1,2,4-triazol-3-yl)-2-pyridinyl]-1-[2-(pyridin-4-ylmethoxy)ethyl]imidazo[4,5-c]pyridine-6-carboxamide
CID 154991766
methane;7-[[4-(5-methyl-1,3,4-oxadiazol-2-yl)phenyl]methyl]-2-(2-propan-2-ylphenyl)-5H-pyrrolo[2,3-d]pyrimidin-6-one;2-(2-propan-2-ylphenyl)-7-[(1R)-1-[4-(triazol-1-yl)phenyl]ethyl]-5H-pyrrolo[2,3-d]pyrimidin-6-one;2-(2-propan-2-ylphenyl)-7-[[4-[3-(trifluoromethyl)pyrazol-1-yl]phenyl]methyl]-5H-pyrrolo[2,3-d]pyrimidin-6-one
CID 157163912
methane;7-[[4-(5-methyl-1,3,4-oxadiazol-2-yl)phenyl]methyl]-2-(2-propan-2-ylphenyl)-5H-pyrrolo[2,3-d]pyrimidin-6-one;7-methyl-2-(2-propan-2-ylphenyl)-9-[(1R)-1-[4-(triazol-1-yl)phenyl]ethyl]purin-8-one;2-(2-propan-2-ylphenyl)-7-[[4-[3-(trifluoromethyl)pyrazol-1-yl]phenyl]methyl]-5H-pyrrolo[2,3-d]pyrimidin-6-one
CID 157371199
16-(4-Imidazo[1,2-a]pyrimidin-2-ylphenyl)-9-phenyl-4,9-diazahexacyclo[13.6.2.02,10.03,8.012,22.019,23]tricosa-1(22),2(10),3(8),4,6,11,13,15,17,19(23),20-undecaene;9-[3-methyl-5-(trifluoromethyl)phenyl]-16-phenyl-4,9-diazahexacyclo[13.6.2.02,10.03,8.012,22.019,23]tricosa-1(22),2(10),3(8),4,6,11,13,15,17,19(23),20-undecaene;2-phenyl-5-(9-phenyl-4,9-diazahexacyclo[13.6.2.02,10.03,8.012,22.019,23]tricosa-1(22),2(10),3(8),4,6,11,13,15,17,19(23),20-undecaen-16-yl)-1,3,4-oxadiazole
CID 158772688
2-[3,5-Bis(5-naphthalen-1-yl-1,3,4-oxadiazol-2-yl)phenyl]-5-naphthalen-1-yl-1,3,4-oxadiazole;3-(4-tert-butylphenyl)-4-(4-ethylphenyl)-5-(4-phenylphenyl)-1,2,4-triazole;2-(4-tert-butylphenyl)-5-(4-phenylphenyl)-1,3,4-oxadiazole;3-(4-tert-butylphenyl)-4-phenyl-5-(4-phenylphenyl)-1,2,4-triazole;2,9-dimethyl-4,7-diphenyl-1,10-phenanthroline;4,7-diphenyl-1,10-phenanthroline;2-[4-[1,1,1,3,3,3-hexafluoro-2-[4-[5-(4-phenylphenyl)-1,3,4-oxadiazol-2-yl]phenyl]propan-2-yl]phenyl]-5-(4-phenylphenyl)-1,3,4-oxadiazole;4-naphthalen-1-yl-3,5-diphenyl-1,2,4-triazole;9-[4-(3-phenylimidazo[4,5-b]pyridin-2-yl)phenyl]carbazole
CID 160130312
1-[4,6-Bis(2-methylbenzimidazol-1-yl)-1,3,5-triazin-2-yl]-2-methylbenzimidazole;9-butan-2-ylcarbazole;2-(4-tert-butylphenyl)-5-(4-phenylphenyl)-1,3,4-oxadiazole;2-(2,4-difluorobenzene-6-id-1-yl)pyridine;bis(iridium);2-phenylpyridine;2-[3-(trifluoromethyl)pyrazol-1-id-5-yl]pyridine
CID 161135612
7-[[4-(5-methyl-1,3,4-oxadiazol-2-yl)phenyl]methyl]-2-(2-propan-2-ylphenyl)-5H-pyrrolo[2,3-d]pyrimidin-6-one;4-[[6-oxo-2-(2-propan-2-ylphenyl)-5H-pyrrolo[2,3-d]pyrimidin-7-yl]methyl]benzonitrile;2-(2-propan-2-ylphenyl)-7-[(1R)-1-[4-(triazol-1-yl)phenyl]ethyl]-5H-pyrrolo[2,3-d]pyrimidin-6-one;2-(2-propan-2-ylphenyl)-7-[[4-[3-(trifluoromethyl)pyrazol-1-yl]phenyl]methyl]-5H-pyrrolo[2,3-d]pyrimidin-6-one
CID 167617890
5-(4-Tert-butylphenyl)-3-[2-[3-[1-[3-(4,7-diphenyl-1,10-phenanthrolin-1-ium-1-yl)phenyl]benzimidazol-2-yl]-5-(1-phenylbenzimidazol-2-yl)phenyl]-3-phenylbenzimidazol-5-yl]-2-(4-phenylphenyl)-1,3,4-oxadiazol-3-ium
CID 91238558
4-(9-Phenylcarbazol-2-yl)-12-(9-phenylpyrimido[4,5-b]indol-7-yl)-8-oxa-6,10-diazatricyclo[7.4.0.02,7]trideca-1(9),2(7),3,5,10,12-hexaene
CID 118517113
4,12-Bis(9-phenylpyrimido[4,5-b]indol-7-yl)-8-oxa-6,10-diazatricyclo[7.4.0.02,7]trideca-1(9),2(7),3,5,10,12-hexaene
CID 118517114
4,12-Bis(9-phenyltriazino[4,5-b]indol-7-yl)-8-oxa-6,10-diazatricyclo[7.4.0.02,7]trideca-1(9),2(7),3,5,10,12-hexaene
CID 118517159

Frequently Asked Questions

What is the IUPAC name of 2,5-bis[9-(4,6-diphenyl-1,3,5-triazin-2-yl)carbazol-2-yl]-1,3,4-oxadiazole;2,5-bis[9-[3-(4,6-diphenyl-1,3,5-triazin-2-yl)phenyl]carbazol-2-yl]-1,3,4-oxadiazole;2-[9-(4,6-diphenylpyrimidin-2-yl)carbazol-2-yl]-5-(9-phenylcarbazol-2-yl)-1,3,4-oxadiazole;2-(9-phenylcarbazol-2-yl)-5-[9-(6-pyridin-3-yl-2-pyridinyl)carbazol-2-yl]-1,3,4-oxadiazole?
The IUPAC name of 2,5-bis[9-(4,6-diphenyl-1,3,5-triazin-2-yl)carbazol-2-yl]-1,3,4-oxadiazole;2,5-bis[9-[3-(4,6-diphenyl-1,3,5-triazin-2-yl)phenyl]carbazol-2-yl]-1,3,4-oxadiazole;2-[9-(4,6-diphenylpyrimidin-2-yl)carbazol-2-yl]-5-(9-phenylcarbazol-2-yl)-1,3,4-oxadiazole;2-(9-phenylcarbazol-2-yl)-5-[9-(6-pyridin-3-yl-2-pyridinyl)carbazol-2-yl]-1,3,4-oxadiazole (CID 158043222) is 2,5-bis[9-(4,6-diphenyl-1,3,5-triazin-2-yl)carbazol-2-yl]-1,3,4-oxadiazole;2,5-bis[9-[3-(4,6-diphenyl-1,3,5-triazin-2-yl)phenyl]carbazol-2-yl]-1,3,4-oxadiazole;2-[9-(4,6-diphenylpyrimidin-2-yl)carbazol-2-yl]-5-(9-phenylcarbazol-2-yl)-1,3,4-oxadiazole;2-(9-phenylcarbazol-2-yl)-5-[9-(6-pyridin-3-yl-2-pyridinyl)carbazol-2-yl]-1,3,4-oxadiazole.
What is the SMILES notation for 2,5-bis[9-(4,6-diphenyl-1,3,5-triazin-2-yl)carbazol-2-yl]-1,3,4-oxadiazole;2,5-bis[9-[3-(4,6-diphenyl-1,3,5-triazin-2-yl)phenyl]carbazol-2-yl]-1,3,4-oxadiazole;2-[9-(4,6-diphenylpyrimidin-2-yl)carbazol-2-yl]-5-(9-phenylcarbazol-2-yl)-1,3,4-oxadiazole;2-(9-phenylcarbazol-2-yl)-5-[9-(6-pyridin-3-yl-2-pyridinyl)carbazol-2-yl]-1,3,4-oxadiazole?
The canonical SMILES for 2,5-bis[9-(4,6-diphenyl-1,3,5-triazin-2-yl)carbazol-2-yl]-1,3,4-oxadiazole;2,5-bis[9-[3-(4,6-diphenyl-1,3,5-triazin-2-yl)phenyl]carbazol-2-yl]-1,3,4-oxadiazole;2-[9-(4,6-diphenylpyrimidin-2-yl)carbazol-2-yl]-5-(9-phenylcarbazol-2-yl)-1,3,4-oxadiazole;2-(9-phenylcarbazol-2-yl)-5-[9-(6-pyridin-3-yl-2-pyridinyl)carbazol-2-yl]-1,3,4-oxadiazole is c1ccc(-c2cc(-c3ccccc3)nc(-n3c4ccccc4c4ccc(-c5nnc(-c6ccc7c8ccccc8n(-c8ccccc8)c7c6)o5)cc43)n2)cc1.c1ccc(-c2nc(-c3ccccc3)nc(-c3cccc(-n4c5ccccc5c5ccc(-c6nnc(-c7ccc8c9ccccc9n(-c9cccc(-c%10nc(-c%11ccccc%11)nc(-c%11ccccc%11)n%10)c9)c8c7)o6)cc54)c3)n2)cc1.c1ccc(-c2nc(-c3ccccc3)nc(-n3c4ccccc4c4ccc(-c5nnc(-c6ccc7c8ccccc8n(-c8nc(-c9ccccc9)nc(-c9ccccc9)n8)c7c6)o5)cc43)n2)cc1.c1ccc(-n2c3ccccc3c3ccc(-c4nnc(-c5ccc6c7ccccc7n(-c7cccc(-c8cccnc8)n7)c6c5)o4)cc32)cc1.
What is the InChIKey of 2,5-bis[9-(4,6-diphenyl-1,3,5-triazin-2-yl)carbazol-2-yl]-1,3,4-oxadiazole;2,5-bis[9-[3-(4,6-diphenyl-1,3,5-triazin-2-yl)phenyl]carbazol-2-yl]-1,3,4-oxadiazole;2-[9-(4,6-diphenylpyrimidin-2-yl)carbazol-2-yl]-5-(9-phenylcarbazol-2-yl)-1,3,4-oxadiazole;2-(9-phenylcarbazol-2-yl)-5-[9-(6-pyridin-3-yl-2-pyridinyl)carbazol-2-yl]-1,3,4-oxadiazole?
The InChIKey is FIPIRMPMFMZXDM-UHFFFAOYSA-N. The full InChI is InChI=1S/C68H42N10O.C56H34N10O.C48H30N6O.C42H26N6O/c1-5-19-43(20-6-1)61-69-62(44-21-7-2-8-22-44)72-65(71-61)47-27-17-29-51(39-47)77-57-33-15-13-31-53(57)55-37-35-49(41-59(55)77)67-75-76-68(79-67)50-36-38-56-54-32-14-16-34-58(54)78(60(56)42-50)52-30-18-28-48(40-52)66-73-63(45-23-9-3-10-24-45)70-64(74-66)46-25-11-4-12-26-46;1-5-17-35(18-6-1)49-57-50(36-19-7-2-8-20-36)60-55(59-49)65-45-27-15-13-25-41(45)43-31-29-39(33-47(43)65)53-63-64-54(67-53)40-30-32-44-42-26-14-16-28-46(42)66(48(44)34-40)56-61-51(37-21-9-3-10-22-37)58-52(62-56)38-23-11-4-12-24-38;1-4-14-31(15-5-1)40-30-41(32-16-6-2-7-17-32)50-48(49-40)54-43-23-13-11-21-37(43)39-27-25-34(29-45(39)54)47-52-51-46(55-47)33-24-26-38-36-20-10-12-22-42(36)53(44(38)28-33)35-18-8-3-9-19-35;1-2-11-30(12-3-1)47-36-16-6-4-13-31(36)33-21-19-27(24-38(33)47)41-45-46-42(49-41)28-20-22-34-32-14-5-7-17-37(32)48(39(34)25-28)40-18-8-15-35(44-40)29-10-9-23-43-26-29/h1-42H;1-34H;1-30H;1-26H.
What are the key properties of 2,5-bis[9-(4,6-diphenyl-1,3,5-triazin-2-yl)carbazol-2-yl]-1,3,4-oxadiazole;2,5-bis[9-[3-(4,6-diphenyl-1,3,5-triazin-2-yl)phenyl]carbazol-2-yl]-1,3,4-oxadiazole;2-[9-(4,6-diphenylpyrimidin-2-yl)carbazol-2-yl]-5-(9-phenylcarbazol-2-yl)-1,3,4-oxadiazole;2-(9-phenylcarbazol-2-yl)-5-[9-(6-pyridin-3-yl-2-pyridinyl)carbazol-2-yl]-1,3,4-oxadiazole?
2,5-bis[9-(4,6-diphenyl-1,3,5-triazin-2-yl)carbazol-2-yl]-1,3,4-oxadiazole;2,5-bis[9-[3-(4,6-diphenyl-1,3,5-triazin-2-yl)phenyl]carbazol-2-yl]-1,3,4-oxadiazole;2-[9-(4,6-diphenylpyrimidin-2-yl)carbazol-2-yl]-5-(9-phenylcarbazol-2-yl)-1,3,4-oxadiazole;2-(9-phenylcarbazol-2-yl)-5-[9-(6-pyridin-3-yl-2-pyridinyl)carbazol-2-yl]-1,3,4-oxadiazole has a molecular weight of 3215.63 g/mol, XLogP of 50.38, 29 rotatable bonds, 0 hydrogen bond donors, and 36 hydrogen bond acceptors.
Where does this data come from?
All data for 2,5-bis[9-(4,6-diphenyl-1,3,5-triazin-2-yl)carbazol-2-yl]-1,3,4-oxadiazole;2,5-bis[9-[3-(4,6-diphenyl-1,3,5-triazin-2-yl)phenyl]carbazol-2-yl]-1,3,4-oxadiazole;2-[9-(4,6-diphenylpyrimidin-2-yl)carbazol-2-yl]-5-(9-phenylcarbazol-2-yl)-1,3,4-oxadiazole;2-(9-phenylcarbazol-2-yl)-5-[9-(6-pyridin-3-yl-2-pyridinyl)carbazol-2-yl]-1,3,4-oxadiazole is sourced from PubChem (CID 158043222), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).